Novo Nordisk A S

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA NVO

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/28/2026

Shares

107,398

Value ($000)

6,754

Weight

0.1%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/28/2026	6,754	0.1%	107,398	12/31/2025
2025 Q3	10/24/2025	5,963	0.1%	112,021	9/30/2025
2025 Q2	7/30/2025	8,161	0.1%	118,240	6/30/2025
2025 Q1	4/24/2025	7,419	0.1%	121,030	3/31/2025
2024 Q4	1/28/2025	9,949	0.1%	113,688	12/31/2024
2024 Q3	10/25/2024	3,660	0.0%	32,131	9/30/2024
2024 Q2	7/17/2024	4,621	0.0%	32,805	6/30/2024
2024 Q1	4/23/2024	2,543	0.0%	20,301	3/31/2024
2023 Q4	2/1/2024	2,345	0.0%	20,436	12/31/2023
2023 Q3	11/3/2023	2,063	0.0%	20,436	9/30/2023
2023 Q2	8/1/2023	1,667	0.0%	10,298	6/30/2023
2023 Q1	5/2/2023	1,639	0.0%	10,298	3/31/2023
2022 Q4	3/2/2023	1,482	0.0%	10,949	12/31/2022
2022 Q3	10/25/2022	1,091	0.0%	10,949	9/30/2022
2022 Q2	7/26/2022	1,220	0.0%	10,949	6/30/2022
2022 Q1	4/13/2022	1,216	0.0%	10,949	3/31/2022
2021 Q4	2/14/2022	1,226	0.0%	10,949	12/31/2021
2021 Q3	11/12/2021	1,067	0.0%	11,109	9/30/2021
2021 Q2	8/13/2021	1,008	0.0%	12,029	6/30/2021
2021 Q1	4/14/2021	819	0.0%	12,148	3/31/2021
2020 Q4	1/14/2021	850	0.0%	12,175	12/31/2020
2020 Q3	10/15/2020	826	0.0%	11,900	9/30/2020
2020 Q2	7/30/2020	779	0.0%	11,900	6/30/2020
2020 Q1	4/15/2020	686	0.0%	11,400	3/31/2020
2019 Q4	1/22/2020	931	0.0%	16,090	12/31/2019
2014 Q1	4/28/2014	83,011	2.3%	1,818,418	3/31/2014
2013 Q4	2/11/2014	67,044	1.8%	362,872	12/31/2013